Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,435 | -49,486 | -28,733 | -9,947 | -41,106 |
| Depreciation Amortization | 3,699 | 1,490 | 964 | 448 | 1,479 |
| Income taxes - deferred | -5,777 | N/A | N/A | N/A | N/A |
| Accounts receivable | -493 | -336 | -63 | 783 | 2,087 |
| Accounts payable and accrued liabilities | 6,781 | 4,945 | 816 | -1,045 | -1,810 |
| Other Working Capital | -7,652 | -3,705 | -1,367 | -3,316 | -3,440 |
| Other Operating Activity | 3,950 | 787 | 2,060 | -827 | 4,476 |
| Operating Cash Flow | $-71,927 | $-46,305 | $-26,323 | $-13,904 | $-38,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -822 | -218 | 50 | -24 | N/A |
| Net Acquisitions | -49,086 | N/A | N/A | N/A | -2,450 |
| Purchase Of Investment | -313,392 | -205,334 | 0 | N/A | N/A |
| Sale Of Investment | 86,483 | 20,000 | N/A | N/A | N/A |
| Other Investing Activity | -1,245 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-278,062 | $-185,552 | $50 | $-24 | $-2,450 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 761 |
| Debt Issued | N/A | N/A | N/A | N/A | 1,774 |
| Debt Repayment | -15,005 | -17,010 | -17,010 | N/A | -5,000 |
| Common Stock Issued | 352,820 | 352,858 | 338,537 | 338,361 | 68,625 |
| Other Financing Activity | -1,704 | -1,704 | -1,149 | -825 | -4,258 |
| Financing Cash Flow | $336,111 | $334,144 | $320,378 | $337,536 | $61,902 |
| Beginning Cash Position | 38,449 | 38,449 | 38,449 | 38,449 | 17,311 |
| End Cash Position | 24,571 | 140,736 | 332,554 | 362,057 | 38,449 |
| Net Cash Flow | $-13,878 | $102,287 | $294,105 | $323,608 | $21,138 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,927 | -46,305 | -26,323 | -13,904 | -38,314 |
| Capital Expenditure | -822 | -344 | -76 | -24 | N/A |
| Free Cash Flow | -72,749 | -46,649 | -26,399 | -13,928 | -38,314 |